Walsh Colin, Director at Attovia Therapeutics, Inc., holds 3.02M shares in Attovia Therapeutics, Inc. (Ticker: ATTO), holds ― shares in Elevation Oncology (Ticker: ELEV). Most recently, Walsh Colin Bought ― shares of Attovia Therapeutics, Inc. on Aug 13, 2026 for an estimated value of $10.29M.
What is the percentage of profitable transactions made by Walsh Colin?
The percentage of profitable transactions made by Walsh Colin is 0%.
What is the average return per transaction made by Walsh Colin?
The average return per transaction made by Walsh Colin is -16.60%.
What stocks does Walsh Colin hold?
Walsh Colin holds: ATTO, ELEV stocks.
What was Walsh Colin’s latest transaction?
Walsh Colin latest transaction was an Informative Buy of $10.29M.
What was Walsh Colin's most profitable transaction?
Walsh Colin’s most profitable transaction was an Informative Buy of ATTO stock on August 13, 2026. The return on the trade was 0.00%.
What is Walsh Colin's role in Attovia Therapeutics, Inc.?
Walsh Colin's role in Attovia Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.